Skip to content

2395.T

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.

プライム · サービス業 · 情報通信・サービスその他 · JP

JPY 1,357.00
+0.52%
Ask drillr

Year over year

Reported trailing growth

Revenue
+0.3%
EBITDA
EBIT
-11.1%
EPS
-7.3%
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
-5.6%
EBITDA
EPS
-22.0%

Three-year CAGR

Revenue
+9.0%
EBITDA
-4.2%
EBIT
-20.3%
Net income
-9.0%
EPS
-9.0%
Free cash flow
+182.6%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026